Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
James Anthony Cannon currently holds 398,050 shares of ZIOPHARM ONCOLOGY INC (ZIOP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James Anthony Cannon has been a net buyer of ZIOP stock. They have purchased $542.5K and sold $0 worth of shares.
James Anthony Cannon's most recent insider trade was on May 7, 2019, when they sold 15,000 shares at $0.70 per share.
James Anthony Cannon serves as Executive at ZIOPHARM ONCOLOGY INC (ZIOP). They have executed 26 insider transactions totaling $542.5K over their tenure at the company.
James Anthony Cannon holds the position of Executive at ZIOPHARM ONCOLOGY INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 18 years and currently hold a stake valued at $0.
James Anthony Cannon has shown a buying trading pattern, with $542.5K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by James Anthony Cannon was on Dec 9, 2009, when they purchased $542.5K worth of ZIOP shares. This transaction involved 175,000 shares at $3.10 per share.
James Anthony Cannon currently owns 398,050 shares of ZIOPHARM ONCOLOGY INC (ZIOP), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of James Anthony Cannon's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. James Anthony Cannon has 26 Form 4 filings on record as an insider at ZIOPHARM ONCOLOGY INC.
Set alerts for James Anthony Cannon and 40,000+ other insiders.